Lack of Hepatocyte Growth Factor Receptor (c-met) Gene Expression in Fulminant Hepatic Failure Livers Before Transplantation

[1]  S. Hirono,et al.  Human hepatocyte growth factor in blood of patients with fulminant hepatic failure , 1991, Digestive Diseases and Sciences.

[2]  Steven E. Wilson,et al.  Expression of HGF, Its Receptor c-met, c-myc, and Albumin in Cirrhotic and Neoplastic Human Liver Tissue , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  J. Ljubimova,et al.  Fulminant hepatic failure in rats: Survival and effect on blood chemistry and liver regeneration , 1996, Hepatology.

[4]  S. Hirono,et al.  Clinical significance of serum hepatocyte growth factor in orthotopic liver transplantation. , 1996, Surgery.

[5]  Elie,et al.  Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure–a multicenter European study , 1996, Hepatology.

[6]  L. Podestá,et al.  Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure , 1995, Hepatology.

[7]  M. Fiorentino,et al.  Overexpression of c‐met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions , 1995, Hepatology.

[8]  R. Rubin,et al.  Histopathological heterogeneity in fulminant hepatic failure , 1995, Hepatology.

[9]  H. Kawasaki,et al.  Serum hepatocyte growth factor levels in liver diseases: Clinical implications , 1995, Hepatology.

[10]  K. Yamada,et al.  Identification of a novel type of alternative splicing of a tyrosine kinase receptor. Juxtamembrane deletion of the c-met protein kinase C serine phosphorylation regulatory site. , 1994, The Journal of biological chemistry.

[11]  L. Lin,et al.  Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. , 1994, Oncogene.

[12]  G. V. Vande Woude,et al.  Met expression and sarcoma tumorigenicity. , 1993, Cancer research.

[13]  P. Ternes,et al.  An improved strategy and a useful housekeeping gene for RNA analysis from formalin-fixed, paraffin-embedded tissues by PCR. , 1993, BioTechniques.

[14]  S. A. Kucharski.  Fulminant hepatic failure. , 1993, Critical care nursing clinics of North America.

[15]  E. Rosen,et al.  Hepatocyte growth factor-scatter factor (HGF-SF) and the c-met receptor. Introduction. , 1993, EXS.

[16]  K. Matsumoto,et al.  Roles of HGF as a pleiotropic factor in organ regeneration. , 1993, EXS.

[17]  M. Naujokas,et al.  Alternative splicing generates isoforms of the met receptor tyrosine kinase which undergo differential processing , 1991, Molecular and cellular biology.

[18]  K. Matsumoto,et al.  Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. , 1991, Biochemical and biophysical research communications.

[19]  G. Michalopoulos,et al.  Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration , 1991, Hepatology.

[20]  G. Michalopoulos,et al.  Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.

[21]  G. Michalopoulos,et al.  Hepatocyte growth factor/hepatopoietin A stimulates the growth of rat kidney proximal tubule epithelial cells (RPTE), rat nonparenchymal liver cells, human melanoma cells, mouse keratinocytes and stimulates anchorage-independent growth of SV-40 transformed RPTE. , 1991, Biochemical and biophysical research communications.

[22]  S. Hirono,et al.  Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme‐linked immunosorbent assay , 1991, Hepatology.

[23]  D. W. Vinter,et al.  Smooth muscle-derived factor stimulates mobility of human tumor cells. , 1990, Invasion & metastasis.

[24]  D. Jones,et al.  Fulminant hepatic failure. , 1989, The Medical clinics of North America.

[25]  S. Hirono,et al.  Clinical significance of human hepatocyte growth factor in blood from patients with fulminant hepatic failure , 1989, Hepatology.

[26]  M. Braun,et al.  Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[27]  N. Fausto,et al.  Analysis of Proto-oncogene Expression During Liver Regeneration and Hepatocarcinogenesis , 1987 .

[28]  J. Yokota,et al.  Alterations of myc, myb, and rasHa proto-oncogenes in cancers are frequent and show clinical correlation. , 1986, Science.

[29]  H. Varmus,et al.  Amplification and enhanced expression of the c-myc oncogene in mouse SEWA tumour cells , 1985, Nature.

[30]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[31]  C. S. Davidson,et al.  The management of fulminant hepatic failure. , 1970, Progress in liver diseases.